Zafgen, Inc. (ZFGN) - NASDAQ
From other sites
Company Description
Zafgen, Inc. is a biopharmaceutical company, which is engaged in the developing of anti-obesity therapeutics that restores normal fat metabolism and regulatory pathways. The company's product: Beloranib, which is under phase 2 clinical development as a treatment for obesity and hyperphagia in... More
Sector: Healthcare
Industry: Biotechnology
Country: United States